Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Locoregional Flap-Based Closure clinical trials

1 of 1 indexed Locoregional Flap-Based Closure trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Locoregional Flap-Based Closure: 1 US clinical trial tracked, 1 recruiting.

Locoregional Flap-Based Closure is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Rhode Island Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition locoregional-flap-based-closure

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Locoregional Flap-Based (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Locoregional Flap-Based Closure

Locoregional Flap-Based Closure lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Locoregional Flap-Based Closure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Locoregional Flap-Based Closure is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Locoregional Flap-Based Closure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Chlorhexidine gluconate solution Device
1 trials
Vancomycin Drug
1 trials

US sites by state

Facility locations filed on Locoregional Flap-Based Closure trials. A trial with sites in several states counts in each.

Rhode Island 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Locoregional Flap-Based Closure page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Locoregional Flap-Based Closure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Rhode Island Hospital sponsors the most Locoregional Flap-Based Closure trials on record, review their full trial history before evaluating a specific study. See Rhode Island Hospital's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Locoregional Flap-Based Closure condition card totals 1 registered trials; most-linked intervention Chlorhexidine gluconate solution; top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.